Astal Laboratories [ASTALLTD] vs Future Enterprises [FELDVR] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Astal Laboratories Ltd. wins in 13 metrics, Future Enterprises Ltd. wins in 4 metrics, with 0 ties. Astal Laboratories Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Astal Laboratories Ltd. Future Enterprises Ltd. Better
P/E Ratio (TTM) 8.92 -0.05 Astal Laboratories Ltd.
Price-to-Book Ratio 1.57 0.06 Future Enterprises Ltd.
Debt-to-Equity Ratio 29.18 -28.41 Astal Laboratories Ltd.
PEG Ratio -0.66 N/A N/A
EV/EBITDA 5.91 -46.57 Astal Laboratories Ltd.
Profit Margin (TTM) 7.11% -131.19% Astal Laboratories Ltd.
Operating Margin (TTM) 6.03% -97.99% Astal Laboratories Ltd.
EBITDA Margin (TTM) 6.03% N/A N/A
Return on Equity 24.80% -238.27% Astal Laboratories Ltd.
Return on Assets (TTM) 14.09% -5.11% Astal Laboratories Ltd.
Free Cash Flow (TTM) $-182.92M $3.90B Future Enterprises Ltd.
1-Year Return -8.03% -31.58% Astal Laboratories Ltd.
Price-to-Sales Ratio (TTM) 1.95 0.07 Future Enterprises Ltd.
Enterprise Value $762.07M $76.07B Future Enterprises Ltd.
EV/Revenue Ratio 0.55 3.47 Astal Laboratories Ltd.
Gross Profit Margin (TTM) 9.78% -43.00% Astal Laboratories Ltd.
Revenue per Share (TTM) $135 $46 Astal Laboratories Ltd.
Earnings per Share (Diluted) $7.13 $-30.54 Astal Laboratories Ltd.
Beta (Stock Volatility) -0.55 0.27 Astal Laboratories Ltd.

Astal Laboratories Ltd. vs Future Enterprises Ltd. Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Astal Laboratories Ltd.4.96%13.85%-0.82%12.34%-6.74%-7.93%
Future Enterprises Ltd.4.62%4.62%2.26%-3.89%-15.79%-13.38%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Astal Laboratories Ltd.-8.03%71.50%71.50%71.50%71.50%71.50%
Future Enterprises Ltd.-31.58%-38.82%-81.69%-85.47%-97.92%-99.12%

Performance & Financial Health Analysis: Astal Laboratories Ltd. vs Future Enterprises Ltd.

MetricASTALLTDFELDVR
Market Information
Market Cap i₹2.68B₹1.49B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i43,5504,402
90 Day Avg. Volume i25,6114,188
Last Close₹81.11₹2.72
52 Week Range₹60.45 - ₹103.20₹2.35 - ₹3.90
% from 52W High-21.41%-30.26%
All-Time High₹131.70 (Sep 09, 2024)₹588.49 (Dec 31, 2007)
% from All-Time High-38.41%-99.54%
Growth Metrics
Quarterly Revenue Growth2.65%-0.13%
Quarterly Earnings Growth-0.05%-0.13%
Financial Health
Profit Margin (TTM) i0.07%-1.31%
Operating Margin (TTM) i0.06%-0.98%
Return on Equity (TTM) i0.25%-2.38%
Debt to Equity (MRQ) i29.18-28.41
Cash & Liquidity
Book Value per Share (MRQ)₹40.48₹52.91
Cash per Share (MRQ)₹4.63₹0.34
Operating Cash Flow (TTM) i₹-116,989,000₹4.00B
Levered Free Cash Flow (TTM) i₹89.25M₹13.64B
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A₹0.00

Valuation & Enterprise Metrics Analysis: Astal Laboratories Ltd. vs Future Enterprises Ltd.

MetricASTALLTD (Apr 24, 2026)FELDVR (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i8.92-0.05
Forward P/E iN/AN/A
PEG Ratio i-0.66N/A
Price to Sales (TTM) i1.950.07
Price to Book (MRQ) i1.570.06
Market Capitalization
Market Capitalization i₹2.68B₹1.49B
Enterprise Value i₹762.07M₹76.07B
Enterprise Value Metrics
Enterprise to Revenue i0.553.47
Enterprise to EBITDA i5.91-46.57
Risk & Other Metrics
Beta i-0.550.27
Book Value per Share (MRQ) i₹40.48₹52.91

Financial Statements Comparison: Astal Laboratories Ltd. vs Future Enterprises Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricASTALLTD (2025)FELDVR (2022)
Revenue/Sales i642.31M21.93B
Cost of Goods Sold i484.81M20.27B
COGS % of Revenue i75.5%92.4%
Gross Profit i157.50M1.66B
Gross Margin i24.5%7.6%
Research & Development iN/AN/A
Operating Income (EBIT) i125.53M-8.29B
Operating Margin i19.5%-37.8%
EBITDA i129.01M-3.45B
EBITDA Margin i20.1%-15.7%
Pre-Tax Income i119.78M-31.73B
Pre-Tax Income % of Revenue i18.6%-144.7%
Income Tax i30.52M0
Income Tax % of Revenue i4.8%0.0%
Net Income (Profit) i89.25M-31.73B
Profit Margin i13.9%-144.7%

Balance Sheet & Liquidity Metrics

MetricASTALLTD (2025)FELDVR (2022)
Cash & Equivalents i17.30M64.40M
Total Current Assets i456.39M30.32B
Total Current Assets % of Revenue i71.1%138.2%
Total Current Liabilities i267.71M82.76B
Total Current Liabilities % of Revenue i41.7%377.3%
Long-Term Debt i4.56M3.14B
Long-Term Debt % of Revenue i0.7%14.3%
Total Shareholders Equity i359.95M-2.63B
Retained Earnings i107.05MN/A
Retained Earnings % of Revenue i16.7%0.0%
Property, Plant & Equipment i032.07B

Cash Flow Statement Comparison

MetricASTALLTD (2025)FELDVR (2022)
Operating Cash Flow i-116.99M-16.24B
Operating Cash Flow % of Revenue i-18.2%-74.1%
Capital Expenditures i-57.75M-100.30M
Free Cash Flow i-182.92M3.90B
FCF Margin i-28.5%17.8%
Debt Repayment i-547,000N/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricASTALLTDFELDVR
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i42.22M494.31M
Float Shares i5.68M322.98M
% Held by Insiders i66.12%72.22%
% Held by Institutions i0.00%0.00%
% Held by Public i33.88%27.78%

Dividend Analysis & Yield Comparison: Astal Laboratories Ltd. vs Future Enterprises Ltd.

MetricASTALLTDFELDVR
Last 12-Month Dividend iN/A₹0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A₹0.00
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/A₹0.00
Ex-Dividend DateN/AN/A